| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.571 | 0.011 | 0.62 | GABA C receptor rho-3 antagonist | 0.62 0.005 DBMET01944 0.487 0.03 DBMET01943 0.374 0.074 DBMET01945 0.374 0.074 DBMET01946 0.38 0.07 DBMET01947 0.416 0.055 DBMET01948 | DBMET01944 | |
| 0.524 | 0.006 | 0.524 | 5 Hydroxytryptamine antagonist | 0.321 0.017 DBMET01944 0.099 0.08 DBMET01943 0.134 0.057 DBMET01945 0.234 0.027 DBMET01946 0.218 0.03 DBMET01947 0.251 0.025 DBMET01948 | ||
| 0.529 | 0.029 | 0.529 | Aldehyde oxidase inhibitor | 0.229 0.091 DBMET01944 0.482 0.035 DBMET01943 0.215 0.097 DBMET01945 0.215 0.097 DBMET01946 0.153 0.136 DBMET01947 0.234 0.089 DBMET01948 | ||
| 0.509 | 0.014 | 0.509 | HERG channel blocker | 0.348 0.038 DBMET01944 0.26 0.062 DBMET01947 0.247 0.067 DBMET01948 | ||
| 0.463 | 0.005 | 0.463 | 5 Hydroxytryptamine 2C antagonist | 0.297 0.009 DBMET01944 0.125 0.034 DBMET01943 0.127 0.033 DBMET01945 0.127 0.033 DBMET01946 0.334 0.008 DBMET01947 0.373 0.006 DBMET01948 | ||
| 0.462 | 0.004 | 0.462 | Dopamine D4 antagonist | 0.119 0.022 DBMET01944 0.097 0.027 DBMET01943 0.071 0.036 DBMET01945 0.071 0.036 DBMET01946 0.121 0.021 DBMET01947 0.192 0.013 DBMET01948 | ||
| 0.448 | 0.006 | 0.448 | 5 Hydroxytryptamine 2B antagonist | 0.276 0.016 DBMET01944 0.139 0.046 DBMET01943 0.159 0.037 DBMET01945 0.159 0.037 DBMET01946 0.176 0.032 DBMET01947 0.193 0.028 DBMET01948 | ||
| 0.457 | 0.019 | 0.457 | Potassium channel (Voltage-sensitive) blocker | 0.305 0.048 DBMET01944 0.21 0.089 DBMET01947 0.199 0.096 DBMET01948 | ||
| 0.443 | 0.008 | 0.443 | 5 Hydroxytryptamine 2 antagonist | 0.256 0.021 DBMET01944 0.114 0.063 DBMET01943 0.138 0.049 DBMET01945 0.138 0.049 DBMET01946 0.244 0.022 DBMET01947 0.298 0.016 DBMET01948 | ||
| 0.413 | 0.005 | 0.413 | 5 Hydroxytryptamine 7 antagonist | 0.212 0.011 DBMET01944 0.084 0.029 DBMET01943 0.09 0.027 DBMET01945 0.09 0.027 DBMET01946 0.158 0.017 DBMET01947 0.194 0.013 DBMET01948 | ||
| 0.476 | 0.07 | 0.476 | Caspase 9 stimulant | 0.436 0.09 DBMET01944 0.416 0.101 DBMET01943 0.385 0.12 DBMET01945 0.385 0.12 DBMET01946 0.281 0.215 DBMET01947 0.258 0.243 DBMET01948 | ||
| 0.439 | 0.039 | 0.497 | MAP kinase kinase 6 inhibitor | 0.497 0.019 DBMET01944 0.328 0.11 DBMET01943 0.313 0.123 DBMET01945 0.313 0.123 DBMET01946 0.44 0.038 DBMET01947 0.417 0.049 DBMET01948 | DBMET01944 | |
| 0.412 | 0.02 | 0.646 | Anticonvulsant | 0.295 0.042 DBMET01944 0.331 0.033 DBMET01943 0.213 0.074 DBMET01945 0.213 0.074 DBMET01946 0.587 0.008 DBMET01947 0.646 0.005 DBMET01948 | DBMET01948 | |
| 0.409 | 0.02 | 0.409 | Sigma receptor agonist | 0.13 0.102 DBMET01943 0.168 0.074 DBMET01945 0.168 0.074 DBMET01946 0.227 0.054 DBMET01947 0.377 0.025 DBMET01948 | ||
| 0.394 | 0.006 | 0.394 | 5 Hydroxytryptamine 1A antagonist | 0.165 0.018 DBMET01944 0.107 0.03 DBMET01945 0.107 0.03 DBMET01946 0.211 0.014 DBMET01947 0.246 0.011 DBMET01948 | ||
| 0.408 | 0.021 | 0.408 | Potassium channel blocker | 0.3 0.046 DBMET01944 0.289 0.05 DBMET01947 0.28 0.053 DBMET01948 | ||
| 0.385 | 0.005 | 0.385 | Toll-Like receptor 9 antagonist | 0.302 0.013 DBMET01944 0.137 0.072 DBMET01943 0.115 0.091 DBMET01945 0.115 0.091 DBMET01946 0.34 0.008 DBMET01947 0.311 0.011 DBMET01948 | ||
| 0.386 | 0.007 | 0.386 | 5 Hydroxytryptamine 2A antagonist | 0.198 0.02 DBMET01944 0.086 0.055 DBMET01943 0.112 0.041 DBMET01945 0.112 0.041 DBMET01946 0.229 0.017 DBMET01947 0.303 0.011 DBMET01948 | ||
| 0.379 | 0.004 | 0.379 | Toll-Like receptor antagonist | 0.317 0.005 DBMET01944 0.221 0.024 DBMET01943 0.114 0.094 DBMET01945 0.114 0.094 DBMET01946 0.255 0.014 DBMET01947 0.219 0.024 DBMET01948 | ||
| 0.381 | 0.007 | 0.381 | 5 Hydroxytryptamine 1 antagonist | 0.167 0.021 DBMET01944 0.087 0.043 DBMET01945 0.087 0.043 DBMET01946 0.169 0.02 DBMET01947 0.196 0.017 DBMET01948 | ||
| 0.439 | 0.069 | 0.441 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.441 0.067 DBMET01944 0.331 0.173 DBMET01943 0.276 0.247 DBMET01945 0.276 0.247 DBMET01946 0.277 0.245 DBMET01947 0.321 0.185 DBMET01948 | DBMET01944 | |
| 0.373 | 0.01 | 0.373 | Alpha adrenoreceptor antagonist | 0.197 0.028 DBMET01944 0.089 0.064 DBMET01943 0.1 0.057 DBMET01945 0.1 0.057 DBMET01946 0.171 0.032 DBMET01947 0.211 0.026 DBMET01948 | ||
| 0.37 | 0.008 | 0.37 | Alpha 1 adrenoreceptor antagonist | 0.177 0.024 DBMET01944 0.096 0.045 DBMET01943 0.108 0.041 DBMET01945 0.108 0.041 DBMET01946 0.141 0.031 DBMET01947 0.173 0.025 DBMET01948 | ||
| 0.424 | 0.063 | 0.452 | Histamine release inhibitor | 0.263 0.146 DBMET01944 0.452 0.049 DBMET01943 | DBMET01943 | |
| 0.385 | 0.025 | 0.424 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.408 0.02 DBMET01944 0.269 0.089 DBMET01943 0.424 0.017 DBMET01945 0.424 0.017 DBMET01946 0.258 0.099 DBMET01947 0.261 0.097 DBMET01948 | DBMET01946 | |
| 0.359 | 0.005 | 0.359 | 5 Hydroxytryptamine 1A agonist | 0.091 0.017 DBMET01944 0.054 0.027 DBMET01943 0.063 0.024 DBMET01945 0.063 0.024 DBMET01946 0.106 0.014 DBMET01947 0.145 0.011 DBMET01948 | ||
| 0.351 | 0.01 | 0.351 | Antiadrenergic | 0.15 0.036 DBMET01944 0.106 0.053 DBMET01943 0.129 0.042 DBMET01945 0.129 0.042 DBMET01946 0.175 0.029 DBMET01947 0.224 0.02 DBMET01948 | ||
| 0.348 | 0.01 | 0.348 | Adrenaline antagonist | 0.147 0.035 DBMET01944 0.103 0.052 DBMET01943 0.121 0.043 DBMET01945 0.121 0.043 DBMET01946 0.173 0.029 DBMET01947 0.222 0.02 DBMET01948 | ||
| 0.333 | 0.008 | 0.333 | Alpha 1a adrenoreceptor antagonist | 0.155 0.023 DBMET01944 0.089 0.041 DBMET01945 0.089 0.041 DBMET01946 0.133 0.026 DBMET01947 0.165 0.021 DBMET01948 | ||
| 0.348 | 0.032 | 0.348 | Psychostimulant | 0.32 0.038 DBMET01944 0.319 0.038 DBMET01943 0.285 0.047 DBMET01945 0.285 0.047 DBMET01946 0.195 0.083 DBMET01948 | ||
| 0.322 | 0.01 | 0.322 | Dopamine antagonist | 0.097 0.04 DBMET01944 0.066 0.058 DBMET01945 0.066 0.058 DBMET01946 0.105 0.036 DBMET01947 0.166 0.023 DBMET01948 | ||
| 0.311 | 0.005 | 0.724 | Dopamine D4 agonist | 0.092 0.016 DBMET01944 0.088 0.017 DBMET01943 0.071 0.023 DBMET01945 0.071 0.023 DBMET01946 0.653 0.003 DBMET01947 0.724 0.002 DBMET01948 | DBMET01948 | |
| 0.306 | 0.005 | 0.306 | Dopamine D3 antagonist | 0.094 0.026 DBMET01944 0.061 0.044 DBMET01943 0.143 0.016 DBMET01947 0.187 0.012 DBMET01948 | ||
| 0.307 | 0.007 | 0.307 | Alpha 1b adrenoreceptor antagonist | 0.146 0.023 DBMET01944 0.063 0.058 DBMET01943 0.082 0.044 DBMET01945 0.082 0.044 DBMET01946 0.091 0.039 DBMET01947 0.111 0.032 DBMET01948 | ||
| 0.299 | 0.005 | 0.35 | Protein kinase C zeta inhibitor | 0.35 0.004 DBMET01944 0.254 0.007 DBMET01943 0.279 0.006 DBMET01945 0.279 0.006 DBMET01946 0.159 0.018 DBMET01947 0.146 0.021 DBMET01948 | DBMET01944 | |
| 0.344 | 0.054 | 0.372 | Calcium channel activator | 0.372 0.037 DBMET01944 0.311 0.081 DBMET01943 0.219 0.186 DBMET01947 0.243 0.155 DBMET01948 | DBMET01944 | |
| 0.289 | 0.005 | 0.289 | Alpha 1 adrenoreceptor agonist | 0.17 0.008 DBMET01944 0.067 0.03 DBMET01943 0.053 0.046 DBMET01945 0.053 0.046 DBMET01946 0.115 0.013 DBMET01947 0.129 0.011 DBMET01948 | ||
| 0.28 | 0.006 | 0.28 | Alpha 1d adrenoreceptor antagonist | 0.117 0.019 DBMET01944 0.085 0.028 DBMET01945 0.085 0.028 DBMET01946 0.075 0.032 DBMET01947 0.089 0.026 DBMET01948 | ||
| 0.33 | 0.061 | 0.501 | 5 Hydroxytryptamine release stimulant | 0.501 0.027 DBMET01944 0.187 0.133 DBMET01943 | DBMET01944 | |
| 0.297 | 0.031 | 0.302 | 5 Hydroxytryptamine 1E antagonist | 0.302 0.029 DBMET01944 0.186 0.147 DBMET01943 0.202 0.128 DBMET01947 0.25 0.074 DBMET01948 | DBMET01944 | |
| 0.276 | 0.011 | 0.276 | Alpha 2b adrenoreceptor antagonist | 0.222 0.019 DBMET01944 0.114 0.063 DBMET01947 0.124 0.055 DBMET01948 | ||
| 0.272 | 0.008 | 0.396 | Histamine H1 receptor antagonist | 0.094 0.045 DBMET01944 0.233 0.011 DBMET01943 0.396 0.005 DBMET01947 0.368 0.005 DBMET01948 | DBMET01947 | |
| 0.268 | 0.012 | 0.268 | Dopamine D2 antagonist | 0.075 0.042 DBMET01944 0.093 0.035 DBMET01947 0.159 0.021 DBMET01948 | ||
| 0.284 | 0.034 | 0.328 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.328 0.016 DBMET01944 0.232 0.092 DBMET01943 0.232 0.093 DBMET01945 0.232 0.093 DBMET01946 0.219 0.118 DBMET01947 0.217 0.123 DBMET01948 | DBMET01944 | |
| 0.257 | 0.008 | 0.257 | 5 Hydroxytryptamine 1 agonist | 0.073 0.027 DBMET01944 0.069 0.029 DBMET01947 0.099 0.021 DBMET01948 | ||
| 0.357 | 0.109 | 0.373 | 5 Hydroxytryptamine release inhibitor | 0.34 0.124 DBMET01944 0.373 0.097 DBMET01943 | DBMET01943 | |
| 0.371 | 0.124 | 0.371 | MAP kinase 1 inhibitor | 0.323 0.157 DBMET01944 0.244 0.241 DBMET01943 | ||
| 0.242 | 0.006 | 0.242 | Alpha adrenoreceptor agonist | 0.213 0.007 DBMET01944 0.094 0.03 DBMET01947 0.096 0.029 DBMET01948 | ||
| 0.239 | 0.007 | 0.646 | Dopamine agonist | 0.091 0.031 DBMET01944 0.102 0.027 DBMET01943 0.09 0.031 DBMET01945 0.09 0.031 DBMET01946 0.552 0.004 DBMET01947 0.646 0.004 DBMET01948 | DBMET01948 | |
| 0.246 | 0.014 | 0.29 | Antihistaminic | 0.095 0.059 DBMET01944 0.102 0.054 DBMET01943 0.29 0.011 DBMET01947 0.281 0.011 DBMET01948 | DBMET01947 | |
| 0.241 | 0.011 | 0.241 | Alpha 2c adrenoreceptor antagonist | 0.172 0.024 DBMET01944 0.112 0.055 DBMET01947 0.121 0.049 DBMET01948 | ||
| 0.238 | 0.014 | 0.285 | Histamine antagonist | 0.085 0.058 DBMET01944 0.088 0.056 DBMET01943 0.285 0.011 DBMET01947 0.275 0.011 DBMET01948 | DBMET01947 | |
| 0.233 | 0.01 | 0.233 | Alpha 2a adrenoreceptor antagonist | 0.2 0.014 DBMET01944 0.083 0.046 DBMET01947 0.096 0.038 DBMET01948 | ||
| 0.278 | 0.059 | 0.316 | Superoxide dismutase inhibitor | 0.298 0.051 DBMET01944 0.316 0.045 DBMET01943 | DBMET01943 | |
| 0.224 | 0.007 | 0.224 | 5 Hydroxytryptamine 1B antagonist | 0.16 0.012 DBMET01944 0.06 0.051 DBMET01947 0.072 0.039 DBMET01948 | ||
| 0.226 | 0.014 | 0.226 | MAP kinase 13 inhibitor | 0.199 0.021 DBMET01944 0.132 0.046 DBMET01945 0.132 0.046 DBMET01946 0.198 0.021 DBMET01947 0.196 0.022 DBMET01948 | ||
| 0.223 | 0.016 | 0.223 | MAP kinase 12 inhibitor | 0.2 0.023 DBMET01944 0.138 0.051 DBMET01945 0.138 0.051 DBMET01946 0.207 0.021 DBMET01947 0.196 0.024 DBMET01948 | ||
| 0.274 | 0.068 | 0.274 | Ca(v)3.3 blocker | 0.2 0.192 DBMET01947 | ||
| 0.214 | 0.011 | 0.234 | 5 Hydroxytryptamine 3A agonist | 0.234 0.007 DBMET01944 0.092 0.086 DBMET01943 0.093 0.085 DBMET01947 0.153 0.034 DBMET01948 | DBMET01944 | |
| 0.213 | 0.013 | 0.402 | 5 Hydroxytryptamine agonist | 0.277 0.009 DBMET01944 0.402 0.005 DBMET01946 0.08 0.042 DBMET01948 | DBMET01946 | |
| 0.204 | 0.005 | 0.204 | Potassium channel (Ca-activated) blocker | 0.183 0.005 DBMET01944 0.098 0.01 DBMET01943 0.069 0.028 DBMET01945 0.069 0.028 DBMET01946 0.09 0.013 DBMET01947 0.095 0.011 DBMET01948 | ||
| 0.203 | 0.005 | 0.203 | Histamine N-methyltransferase inhibitor | 0.187 0.006 DBMET01944 0.152 0.013 DBMET01943 0.133 0.022 DBMET01945 0.133 0.022 DBMET01946 0.128 0.025 DBMET01947 0.096 0.05 DBMET01948 | ||
| 0.233 | 0.036 | 0.256 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.256 0.03 DBMET01944 0.154 0.063 DBMET01945 0.154 0.063 DBMET01946 | DBMET01944 | |
| 0.226 | 0.03 | 0.232 | 5 Hydroxytryptamine 3E antagonist | 0.232 0.026 DBMET01944 0.167 0.145 DBMET01947 0.201 0.061 DBMET01948 | DBMET01944 | |
| 0.248 | 0.052 | 0.248 | ErbB-1 antagonist | 0.228 0.065 DBMET01944 0.182 0.112 DBMET01943 0.162 0.149 DBMET01945 0.162 0.149 DBMET01946 0.164 0.145 DBMET01947 | ||
| 0.224 | 0.028 | 0.277 | Ribosomal protein S6 kinase inhibitor | 0.277 0.014 DBMET01944 0.124 0.086 DBMET01943 0.166 0.055 DBMET01947 0.169 0.053 DBMET01948 | DBMET01944 | |
| 0.219 | 0.028 | 0.219 | Nav1.2 sodium channel blocker | 0.124 0.079 DBMET01944 0.129 0.073 DBMET01945 0.129 0.073 DBMET01946 | ||
| 0.196 | 0.011 | 0.196 | Dopamine D1 antagonist | 0.086 0.03 DBMET01944 0.07 0.04 DBMET01943 0.065 0.044 DBMET01945 0.065 0.044 DBMET01946 0.061 0.049 DBMET01947 0.104 0.024 DBMET01948 | ||
| 0.247 | 0.061 | 0.297 | MAP-kinase-activated kinase 5 inhibitor | 0.297 0.032 DBMET01944 0.171 0.146 DBMET01943 0.237 0.068 DBMET01945 0.237 0.068 DBMET01946 | DBMET01944 | |
| 0.204 | 0.023 | 0.204 | Nav1.3 sodium channel blocker | 0.106 0.09 DBMET01944 0.114 0.081 DBMET01945 0.114 0.081 DBMET01946 | ||
| 0.198 | 0.02 | 0.198 | Nav1.6 sodium channel blocker | 0.152 0.052 DBMET01944 0.14 0.067 DBMET01945 0.14 0.067 DBMET01946 | ||
| 0.192 | 0.016 | 0.308 | Mediator release inhibitor | 0.308 0.007 DBMET01943 0.098 0.072 DBMET01947 0.1 0.07 DBMET01948 | DBMET01943 | |
| 0.179 | 0.004 | 0.179 | Potassium channel small-conductance Ca-activated blocker | 0.172 0.004 DBMET01944 0.055 0.021 DBMET01943 0.06 0.018 DBMET01947 0.053 0.022 DBMET01948 | ||
| 0.252 | 0.079 | 0.423 | DNA damaging | 0.254 0.078 DBMET01944 0.192 0.123 DBMET01943 0.21 0.107 DBMET01945 0.21 0.107 DBMET01946 0.423 0.024 DBMET01947 0.373 0.034 DBMET01948 | DBMET01947 | |
| 0.232 | 0.062 | 0.298 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.298 0.044 DBMET01944 0.146 0.115 DBMET01945 0.146 0.115 DBMET01946 | DBMET01944 | |
| 0.186 | 0.017 | 0.2 | Protein kinase C gamma inhibitor | 0.2 0.014 DBMET01944 0.136 0.04 DBMET01943 0.166 0.024 DBMET01945 0.166 0.024 DBMET01946 0.133 0.043 DBMET01947 0.14 0.038 DBMET01948 | DBMET01944 | |
| 0.207 | 0.039 | 0.207 | Acetylcholine M1 receptor antagonist | 0.143 0.081 DBMET01944 0.125 0.102 DBMET01943 0.116 0.114 DBMET01945 0.116 0.114 DBMET01946 0.125 0.101 DBMET01948 | ||
| 0.197 | 0.03 | 0.257 | GABA C receptor rho-2 antagonist | 0.257 0.01 DBMET01944 0.167 0.054 DBMET01943 0.129 0.107 DBMET01945 0.129 0.107 DBMET01946 | DBMET01944 | |
| 0.227 | 0.061 | 0.303 | Anesthetic general | 0.149 0.115 DBMET01944 0.303 0.032 DBMET01943 0.208 0.07 DBMET01945 0.208 0.07 DBMET01946 | DBMET01943 | |
| 0.187 | 0.021 | 0.222 | GABA receptor agonist | 0.222 0.014 DBMET01944 0.173 0.026 DBMET01943 0.142 0.04 DBMET01945 0.142 0.04 DBMET01946 0.157 0.032 DBMET01947 0.135 0.045 DBMET01948 | DBMET01944 | |
| 0.221 | 0.055 | 0.231 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.231 0.051 DBMET01944 0.211 0.059 DBMET01945 0.211 0.059 DBMET01946 | DBMET01944 | |
| 0.185 | 0.02 | 0.185 | Alpha 2 adrenoreceptor antagonist | 0.157 0.025 DBMET01944 0.089 0.056 DBMET01947 0.103 0.045 DBMET01948 | ||
| 0.177 | 0.016 | 0.177 | Multidrug resistance-associated protein 1 inhibitor | 0.121 0.047 DBMET01944 0.146 0.027 DBMET01943 0.097 0.084 DBMET01945 0.097 0.084 DBMET01946 0.116 0.053 DBMET01947 0.119 0.049 DBMET01948 | ||
| 0.164 | 0.004 | 0.169 | 5 Hydroxytryptamine 3A antagonist | 0.169 0.004 DBMET01944 0.07 0.042 DBMET01943 0.099 0.017 DBMET01947 0.1 0.016 DBMET01948 | DBMET01944 | |
| 0.198 | 0.038 | 0.302 | Activin receptor-like kinase 2 inhibitor | 0.302 0.012 DBMET01944 | DBMET01944 | |
| 0.232 | 0.073 | 0.232 | Cyclic AMP phosphodiesterase inhibitor | 0.226 0.077 DBMET01944 | ||
| 0.194 | 0.038 | 0.234 | Neurotensin receptor agonist | 0.221 0.027 DBMET01944 0.234 0.024 DBMET01943 0.141 0.127 DBMET01947 | DBMET01943 | |
| 0.217 | 0.062 | 0.217 | Neurotrophic factor enhancer | 0.167 0.114 DBMET01944 0.209 0.068 DBMET01943 | ||
| 0.158 | 0.005 | 0.185 | Toll-Like receptor 7 antagonist | 0.185 0.005 DBMET01944 0.076 0.041 DBMET01943 0.065 0.051 DBMET01945 0.065 0.051 DBMET01946 0.086 0.032 DBMET01947 0.064 0.051 DBMET01948 | DBMET01944 | |
| 0.166 | 0.014 | 0.166 | 5 Hydroxytryptamine 1F antagonist | 0.158 0.015 DBMET01944 0.063 0.056 DBMET01943 0.068 0.052 DBMET01948 | ||
| 0.237 | 0.088 | 0.308 | Interleukin agonist | 0.223 0.1 DBMET01944 0.308 0.044 DBMET01943 | DBMET01943 | |
| 0.155 | 0.008 | 0.198 | Bromodomain-containing protein 2 inhibitor | 0.198 0.004 DBMET01944 0.126 0.019 DBMET01943 | DBMET01944 | |
| 0.18 | 0.033 | 0.222 | Glutamate receptor antagonist | 0.222 0.02 DBMET01944 0.178 0.034 DBMET01943 0.2 0.026 DBMET01947 0.179 0.034 DBMET01948 | DBMET01944 | |
| 0.214 | 0.067 | 0.231 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.231 0.058 DBMET01944 0.211 0.069 DBMET01945 0.211 0.069 DBMET01946 | DBMET01944 | |
| 0.159 | 0.012 | 0.159 | Acetylcholine release stimulant | 0.138 0.026 DBMET01944 0.117 0.054 DBMET01943 0.104 0.079 DBMET01947 | ||
| 0.149 | 0.004 | 0.149 | Dopamine D3 agonist | 0.056 0.016 DBMET01944 0.079 0.009 DBMET01943 0.059 0.014 DBMET01945 0.059 0.014 DBMET01946 0.069 0.011 DBMET01947 0.087 0.008 DBMET01948 | ||
| 0.147 | 0.004 | 0.147 | 5 Hydroxytryptamine 7 agonist | 0.104 0.006 DBMET01944 0.061 0.029 DBMET01943 0.053 0.045 DBMET01945 0.053 0.045 DBMET01946 0.065 0.025 DBMET01947 0.086 0.01 DBMET01948 | ||
| 0.152 | 0.009 | 0.208 | 5 Hydroxytryptamine 3 antagonist | 0.208 0.005 DBMET01944 0.055 0.042 DBMET01946 0.056 0.04 DBMET01947 0.06 0.036 DBMET01948 | DBMET01944 | |
| 0.175 | 0.034 | 0.175 | Neuropeptide Y1 antagonist | 0.138 0.084 DBMET01944 0.124 0.115 DBMET01943 | ||
| 0.152 | 0.016 | 0.152 | 5 Hydroxytryptamine uptake inhibitor | 0.118 0.021 DBMET01944 0.066 0.041 DBMET01948 | ||
| 0.145 | 0.013 | 0.145 | 5 Hydroxytryptamine 1D antagonist | 0.137 0.014 DBMET01944 0.059 0.05 DBMET01948 | ||
| 0.137 | 0.007 | 0.137 | Dopamine D2 agonist | 0.039 0.035 DBMET01944 0.059 0.021 DBMET01943 0.048 0.028 DBMET01945 0.048 0.028 DBMET01946 0.097 0.011 DBMET01947 0.135 0.007 DBMET01948 | ||
| 0.137 | 0.008 | 0.189 | 5 Hydroxytryptamine 6 antagonist | 0.189 0.004 DBMET01944 0.051 0.047 DBMET01947 0.056 0.04 DBMET01948 | DBMET01944 | |
| 0.137 | 0.009 | 0.15 | 5 Hydroxytryptamine 5A antagonist | 0.15 0.008 DBMET01944 | DBMET01944 | |
| 0.141 | 0.015 | 0.141 | Lanosterol 14 alpha demethylase inhibitor | 0.133 0.019 DBMET01944 0.131 0.021 DBMET01943 0.084 0.082 DBMET01945 0.084 0.082 DBMET01946 0.089 0.073 DBMET01947 0.096 0.062 DBMET01948 | ||
| 0.135 | 0.009 | 0.151 | 5 Hydroxytryptamine 5 antagonist | 0.151 0.007 DBMET01944 | DBMET01944 | |
| 0.166 | 0.044 | 0.225 | Sodium channel (voltage-gated) blocker | 0.225 0.021 DBMET01944 | DBMET01944 | |
| 0.133 | 0.012 | 0.157 | Nicotinic alpha4beta2 receptor antagonist | 0.157 0.007 DBMET01944 | DBMET01944 | |
| 0.122 | 0.005 | 0.178 | Toll-Like receptor 8 antagonist | 0.178 0.003 DBMET01944 0.054 0.036 DBMET01943 | DBMET01944 | |
| 0.237 | 0.12 | 0.286 | Nootropic | 0.247 0.11 DBMET01944 0.286 0.082 DBMET01947 0.281 0.084 DBMET01948 | DBMET01947 | |
| 0.239 | 0.122 | 0.239 | Caspase 3 stimulant | 0.195 0.177 DBMET01944 0.202 0.166 DBMET01943 0.2 0.169 DBMET01945 0.2 0.169 DBMET01946 | ||
| 0.142 | 0.03 | 0.142 | Insulin receptor antagonist | 0.104 0.056 DBMET01944 | ||
| 0.119 | 0.009 | 0.159 | 5 Hydroxytryptamine 3 agonist | 0.159 0.004 DBMET01944 0.057 0.053 DBMET01943 | DBMET01944 | |
| 0.13 | 0.021 | 0.186 | NMDA 2 receptor antagonist | 0.151 0.016 DBMET01944 0.186 0.011 DBMET01943 0.073 0.049 DBMET01947 0.085 0.041 DBMET01948 | DBMET01943 | |
| 0.271 | 0.165 | 0.271 | Analgesic | |||
| 0.129 | 0.023 | 0.156 | Acetylcholine nicotinic agonist | 0.156 0.015 DBMET01944 | DBMET01944 | |
| 0.149 | 0.044 | 0.149 | Ca2+-transporting ATPase inhibitor | 0.142 0.067 DBMET01943 0.13 0.119 DBMET01945 0.13 0.119 DBMET01946 0.141 0.071 DBMET01948 | ||
| 0.143 | 0.039 | 0.187 | Interleukin 8 antagonist | 0.187 0.017 DBMET01944 0.142 0.04 DBMET01943 0.125 0.055 DBMET01945 0.125 0.055 DBMET01946 0.104 0.087 DBMET01948 | DBMET01944 | |
| 0.149 | 0.046 | 0.153 | Antibacterial (Helicobacter pylori) | 0.122 0.078 DBMET01944 0.123 0.077 DBMET01943 0.153 0.044 DBMET01947 0.136 0.06 DBMET01948 | DBMET01947 | |
| 0.19 | 0.089 | 0.378 | Platelet aggregation inhibitor | 0.158 0.12 DBMET01944 0.378 0.021 DBMET01943 0.358 0.024 DBMET01947 0.305 0.035 DBMET01948 | DBMET01943 | |
| 0.152 | 0.05 | 0.16 | Pregnane X receptor agonist | 0.16 0.037 DBMET01944 0.138 0.077 DBMET01943 | DBMET01944 | |
| 0.106 | 0.005 | 0.106 | 5 Hydroxytryptamine 4 antagonist | 0.061 0.023 DBMET01944 0.058 0.026 DBMET01943 0.062 0.022 DBMET01945 0.062 0.022 DBMET01946 0.056 0.028 DBMET01948 | ||
| 0.117 | 0.017 | 0.149 | Protein kinase C alpha inhibitor | 0.149 0.01 DBMET01944 0.068 0.046 DBMET01943 0.087 0.029 DBMET01945 0.087 0.029 DBMET01946 0.069 0.045 DBMET01947 0.068 0.047 DBMET01948 | DBMET01944 | |
| 0.111 | 0.011 | 0.155 | 5 Hydroxytryptamine 2A agonist | 0.155 0.005 DBMET01944 0.076 0.031 DBMET01948 | DBMET01944 | |
| 0.145 | 0.045 | 0.145 | DNA intercalator | 0.105 0.068 DBMET01944 0.091 0.084 DBMET01943 0.099 0.075 DBMET01945 0.099 0.075 DBMET01946 0.098 0.076 DBMET01947 | ||
| 0.166 | 0.066 | 0.184 | Cyclin-dependent kinase 3 inhibitor | 0.184 0.045 DBMET01944 0.137 0.131 DBMET01943 | DBMET01944 | |
| 0.132 | 0.034 | 0.245 | Protein kinase C mu inhibitor | 0.245 0.008 DBMET01944 0.114 0.046 DBMET01943 0.176 0.017 DBMET01945 0.176 0.017 DBMET01946 | DBMET01944 | |
| 0.108 | 0.01 | 0.109 | Protein kinase C beta inhibitor | 0.109 0.01 DBMET01944 0.079 0.032 DBMET01943 0.092 0.018 DBMET01945 0.092 0.018 DBMET01946 0.072 0.044 DBMET01947 0.078 0.034 DBMET01948 | DBMET01944 | |
| 0.156 | 0.059 | 0.184 | MAP kinase 3 inhibitor | 0.184 0.032 DBMET01944 0.131 0.103 DBMET01943 0.135 0.096 DBMET01945 0.135 0.096 DBMET01946 | DBMET01944 | |
| 0.129 | 0.032 | 0.195 | NMDA receptor antagonist | 0.138 0.028 DBMET01944 0.195 0.015 DBMET01943 0.152 0.024 DBMET01947 0.194 0.015 DBMET01948 | DBMET01943 | |
| 0.151 | 0.058 | 0.188 | Sodium channel blocker | 0.188 0.037 DBMET01944 | DBMET01944 | |
| 0.142 | 0.05 | 0.24 | Platelet activating factor antagonist | 0.102 0.077 DBMET01944 0.1 0.079 DBMET01945 0.24 0.018 DBMET01947 0.187 0.03 DBMET01948 | DBMET01947 | |
| 0.111 | 0.02 | 0.16 | Benzodiazepine agonist | 0.151 0.008 DBMET01944 0.079 0.041 DBMET01945 0.109 0.021 DBMET01946 0.16 0.006 DBMET01947 0.153 0.007 DBMET01948 | DBMET01947 | |
| 0.096 | 0.005 | 0.096 | 5 Hydroxytryptamine 3B antagonist | 0.09 0.005 DBMET01944 0.032 0.03 DBMET01948 | ||
| 0.219 | 0.13 | 0.289 | Hypoxia-inducible factor 1 alpha inhibitor | 0.289 0.071 DBMET01944 0.25 0.1 DBMET01943 | DBMET01944 | |
| 0.099 | 0.009 | 0.099 | Dopamine D5 antagonist | 0.045 0.029 DBMET01945 0.045 0.029 DBMET01946 0.046 0.028 DBMET01947 0.067 0.016 DBMET01948 | ||
| 0.13 | 0.041 | 0.232 | Activin receptor-like kinase 4 inhibitor | 0.232 0.009 DBMET01944 | DBMET01944 | |
| 0.109 | 0.022 | 0.109 | Acetylcholine M4 receptor antagonist | 0.085 0.042 DBMET01944 | ||
| 0.1 | 0.014 | 0.123 | Phospholipase D inhibitor | 0.123 0.005 DBMET01944 0.104 0.013 DBMET01943 | DBMET01944 | |
| 0.095 | 0.009 | 0.113 | MDM2 inhibitor | 0.088 0.012 DBMET01944 0.113 0.004 DBMET01943 0.073 0.031 DBMET01948 | DBMET01943 | |
| 0.177 | 0.091 | 0.224 | Focal adhesion kinase 2 inhibitor | 0.224 0.052 DBMET01944 | DBMET01944 | |
| 0.136 | 0.051 | 0.18 | Glycogen synthase kinase-3 beta inhibitor | 0.18 0.034 DBMET01944 0.128 0.056 DBMET01946 | DBMET01944 | |
| 0.089 | 0.004 | 0.162 | Methionyl aminopeptidase 1 inhibitor | 0.162 0.003 DBMET01944 0.069 0.004 DBMET01943 0.037 0.014 DBMET01947 | DBMET01944 | |
| 0.113 | 0.029 | 0.137 | MAP kinase 11 inhibitor | 0.114 0.028 DBMET01944 0.134 0.021 DBMET01947 0.137 0.02 DBMET01948 | DBMET01948 | |
| 0.16 | 0.077 | 0.214 | Heat shock protein 90 alpha antagonist | 0.214 0.041 DBMET01944 0.193 0.054 DBMET01947 0.169 0.07 DBMET01948 | DBMET01944 | |
| 0.114 | 0.032 | 0.117 | Platelet growth factor antagonist | 0.117 0.031 DBMET01944 0.084 0.053 DBMET01943 | DBMET01944 | |
| 0.086 | 0.005 | 0.107 | DNA gyrase subunit B inhibitor | 0.095 0.005 DBMET01944 0.107 0.005 DBMET01943 | DBMET01943 | |
| 0.2 | 0.121 | 0.205 | MAP kinase kinase 3 inhibitor | 0.205 0.109 DBMET01944 | DBMET01944 | |
| 0.16 | 0.086 | 0.201 | 3C-like protease (Human coronavirus) inhibitor | 0.201 0.051 DBMET01944 | DBMET01944 | |
| 0.209 | 0.135 | 0.269 | Gastrin inhibitor | 0.269 0.059 DBMET01943 | DBMET01943 | |
| 0.117 | 0.044 | 0.129 | Creatine kinase inhibitor | 0.129 0.035 DBMET01943 0.097 0.063 DBMET01948 | DBMET01943 | |
| 0.104 | 0.031 | 0.104 | Telomerase inhibitor | |||
| 0.158 | 0.086 | 0.169 | Antipruritic | 0.169 0.075 DBMET01943 | DBMET01943 | |
| 0.118 | 0.048 | 0.118 | Butyrylcholinesterase inhibitor | |||
| 0.086 | 0.018 | 0.101 | Nicotinic neuronal receptor agonist | 0.101 0.012 DBMET01944 | DBMET01944 | |
| 0.174 | 0.107 | 0.195 | EphB2 antagonist | 0.195 0.091 DBMET01944 | DBMET01944 | |
| 0.071 | 0.005 | 0.071 | Nerve growth factor antagonist | 0.05 0.018 DBMET01944 0.066 0.007 DBMET01943 0.039 0.038 DBMET01945 0.039 0.038 DBMET01946 0.045 0.025 DBMET01947 0.055 0.013 DBMET01948 | ||
| 0.122 | 0.055 | 0.205 | Polo-like kinase-4 inhibitor | 0.205 0.014 DBMET01944 0.112 0.064 DBMET01947 0.101 0.076 DBMET01948 | DBMET01944 | |
| 0.177 | 0.111 | 0.227 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.227 0.073 DBMET01944 | DBMET01944 | |
| 0.088 | 0.022 | 0.125 | DNA gyrase inhibitor | 0.111 0.015 DBMET01944 0.092 0.02 DBMET01943 0.125 0.012 DBMET01947 0.116 0.014 DBMET01948 | DBMET01947 | |
| 0.082 | 0.016 | 0.082 | Histamine H3 receptor antagonist | |||
| 0.117 | 0.053 | 0.128 | MAP kinase kinase kinase inhibitor | 0.128 0.046 DBMET01944 0.084 0.082 DBMET01947 | DBMET01944 | |
| 0.157 | 0.092 | 0.205 | Tumour necrosis factor antagonist | 0.205 0.05 DBMET01944 0.171 0.076 DBMET01947 0.164 0.083 DBMET01948 | DBMET01944 | |
| 0.081 | 0.018 | 0.081 | Nicotinic alpha7 receptor agonist | 0.055 0.036 DBMET01944 | ||
| 0.1 | 0.037 | 0.119 | GABA A receptor agonist | 0.119 0.024 DBMET01944 0.088 0.05 DBMET01947 0.075 0.074 DBMET01948 | DBMET01944 | |
| 0.177 | 0.117 | 0.177 | Antiamyloidogenic | 0.16 0.134 DBMET01943 | ||
| 0.088 | 0.028 | 0.113 | MAP kinase kinase 8 inhibitor | 0.113 0.017 DBMET01944 | DBMET01944 | |
| 0.086 | 0.027 | 0.093 | MAP kinase 7 inhibitor | 0.093 0.014 DBMET01944 | DBMET01944 | |
| 0.118 | 0.059 | 0.118 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.098 DBMET01944 | ||
| 0.12 | 0.061 | 0.164 | Glycogen synthase kinase-3 inhibitor | 0.164 0.04 DBMET01944 0.107 0.073 DBMET01946 | DBMET01944 | |
| 0.154 | 0.095 | 0.154 | ATPase inhibitor | 0.144 0.113 DBMET01944 0.139 0.122 DBMET01943 | ||
| 0.142 | 0.084 | 0.142 | Cholinergic | |||
| 0.143 | 0.086 | 0.226 | Cyclin-dependent kinase 8 inhibitor | 0.226 0.023 DBMET01944 | DBMET01944 | |
| 0.101 | 0.046 | 0.101 | Acetylcholine agonist | 0.099 0.047 DBMET01944 | ||
| 0.129 | 0.075 | 0.138 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.138 0.069 DBMET01944 | DBMET01944 | |
| 0.099 | 0.046 | 0.23 | Pim-3 kinase inhibitor | 0.23 0.006 DBMET01944 | DBMET01944 | |
| 0.138 | 0.085 | 0.138 | Cytidine deaminase inhibitor | 0.122 0.099 DBMET01944 | ||
| 0.066 | 0.014 | 0.106 | Histamine H4 receptor antagonist | 0.106 0.005 DBMET01944 | DBMET01944 | |
| 0.071 | 0.019 | 0.17 | 5 Hydroxytryptamine 2 agonist | 0.17 0.005 DBMET01944 | DBMET01944 | |
| 0.106 | 0.054 | 0.183 | GABA C receptor rho-1 antagonist | 0.183 0.011 DBMET01944 0.106 0.055 DBMET01943 | DBMET01944 | |
| 0.056 | 0.005 | 0.219 | Kynurenine 3 monooxygenase inhibitor | 0.036 0.011 DBMET01944 0.219 0.002 DBMET01943 | DBMET01943 | |
| 0.065 | 0.016 | 0.081 | Bromodomain-containing protein 3 inhibitor | 0.081 0.009 DBMET01944 | DBMET01944 | |
| 0.07 | 0.021 | 0.091 | MAP kinase kinase 9 inhibitor | 0.091 0.012 DBMET01944 | DBMET01944 | |
| 0.106 | 0.059 | 0.138 | Nav1.1 sodium channel blocker | 0.138 0.038 DBMET01945 0.138 0.038 DBMET01946 | DBMET01946 | |
| 0.055 | 0.008 | 0.055 | Heme oxygenase inhibitor | 0.044 0.027 DBMET01944 0.049 0.015 DBMET01943 0.044 0.025 DBMET01948 | ||
| 0.069 | 0.024 | 0.069 | Sigma receptor antagonist | 0.042 0.039 DBMET01948 | ||
| 0.21 | 0.165 | 0.302 | Vasodilator, peripheral | 0.224 0.15 DBMET01944 0.302 0.096 DBMET01943 0.19 0.188 DBMET01945 0.19 0.188 DBMET01946 0.223 0.151 DBMET01947 0.257 0.122 DBMET01948 | DBMET01943 | |
| 0.111 | 0.067 | 0.139 | Nav1.5 sodium channel blocker | 0.139 0.035 DBMET01944 | DBMET01944 | |
| 0.066 | 0.022 | 0.077 | Histamine agonist | 0.077 0.015 DBMET01944 | DBMET01944 | |
| 0.098 | 0.054 | 0.106 | Hepatocyte growth factor antagonist | 0.106 0.045 DBMET01944 | DBMET01944 | |
| 0.07 | 0.028 | 0.085 | Cyclin D1 inhibitor | 0.085 0.014 DBMET01944 | DBMET01944 | |
| 0.134 | 0.093 | 0.164 | Heat shock protein 90 antagonist | 0.164 0.061 DBMET01944 0.132 0.094 DBMET01947 0.122 0.11 DBMET01948 | DBMET01944 | |
| 0.059 | 0.017 | 0.059 | CC chemokine 4 receptor antagonist | 0.051 0.026 DBMET01944 0.05 0.028 DBMET01943 | ||
| 0.07 | 0.029 | 0.093 | Corticotropin releasing factor 2 receptor antagonist | 0.093 0.009 DBMET01944 | DBMET01944 | |
| 0.07 | 0.03 | 0.07 | Dopamine uptake inhibitor | |||
| 0.07 | 0.03 | 0.07 | Acetylcholine M5 receptor antagonist | |||
| 0.061 | 0.021 | 0.061 | Alpha 1L adrenoreceptor antagonist | |||
| 0.094 | 0.054 | 0.112 | Polo-like kinase-1 inhibitor | 0.112 0.035 DBMET01944 | DBMET01944 | |
| 0.046 | 0.007 | 0.046 | Protein kinase C beta II inhibitor | 0.041 0.01 DBMET01944 0.033 0.02 DBMET01945 0.033 0.02 DBMET01946 0.033 0.02 DBMET01947 0.036 0.015 DBMET01948 | ||
| 0.086 | 0.048 | 0.1 | Transforming growth factor beta 3 antagonist | 0.1 0.024 DBMET01944 | DBMET01944 | |
| 0.071 | 0.034 | 0.081 | Adrenaline uptake inhibitor | 0.081 0.026 DBMET01944 | DBMET01944 | |
| 0.054 | 0.017 | 0.072 | Parathyroid hormone antagonist | 0.072 0.006 DBMET01944 0.05 0.021 DBMET01943 | DBMET01944 | |
| 0.148 | 0.111 | 0.175 | Death-associated protein kinase 2 inhibitor | 0.175 0.06 DBMET01944 | DBMET01944 | |
| 0.066 | 0.029 | 0.073 | Phosphodiesterase 1A inhibitor | 0.073 0.021 DBMET01944 | DBMET01944 | |
| 0.075 | 0.038 | 0.151 | Nav1.7 sodium channel blocker | 0.151 0.011 DBMET01944 | DBMET01944 | |
| 0.075 | 0.039 | 0.075 | Acetylcholine M5 receptor agonist | 0.073 0.041 DBMET01944 | ||
| 0.137 | 0.101 | 0.158 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.158 0.058 DBMET01944 | DBMET01944 | |
| 0.096 | 0.061 | 0.096 | Phosphodiesterase 6D inhibitor | |||
| 0.09 | 0.055 | 0.094 | Insulin growth factor antagonist | 0.094 0.051 DBMET01944 | DBMET01944 | |
| 0.049 | 0.014 | 0.168 | 5 Hydroxytryptamine 2B agonist | 0.168 0.003 DBMET01944 | DBMET01944 | |
| 0.092 | 0.058 | 0.098 | Glutamate release inhibitor | 0.098 0.045 DBMET01943 | DBMET01943 | |
| 0.087 | 0.053 | 0.185 | MAP-kinase-activated kinase inhibitor | 0.185 0.007 DBMET01944 | DBMET01944 | |
| 0.048 | 0.015 | 0.048 | p53 inhibitor | 0.048 0.015 DBMET01943 | ||
| 0.075 | 0.042 | 0.167 | Cyclin B3 inhibitor | 0.167 0.01 DBMET01944 0.093 0.031 DBMET01945 0.093 0.031 DBMET01946 | DBMET01944 | |
| 0.065 | 0.032 | 0.072 | Calcium channel T-type blocker | 0.063 0.034 DBMET01947 0.072 0.026 DBMET01948 | DBMET01948 | |
| 0.062 | 0.029 | 0.089 | Protein kinase C epsilon inhibitor | 0.089 0.016 DBMET01944 | DBMET01944 | |
| 0.046 | 0.014 | 0.046 | Delayed rectifier potassium channel blocker | |||
| 0.066 | 0.035 | 0.097 | Cyclin-dependent kinase 6 inhibitor | 0.097 0.011 DBMET01944 | DBMET01944 | |
| 0.085 | 0.054 | 0.089 | Insulin like growth factor 1 antagonist | 0.089 0.05 DBMET01944 | DBMET01944 | |
| 0.074 | 0.043 | 0.074 | Amidase inhibitor | |||
| 0.129 | 0.099 | 0.129 | NOS3 expression enhancer | |||
| 0.058 | 0.029 | 0.062 | 5 Hydroxytryptamine 1B agonist | 0.062 0.024 DBMET01944 0.048 0.047 DBMET01945 0.048 0.047 DBMET01946 | DBMET01944 | |
| 0.172 | 0.143 | 0.172 | Spasmolytic | |||
| 0.194 | 0.165 | 0.259 | 5 Hydroxytryptamine uptake stimulant | 0.259 0.073 DBMET01944 0.201 0.15 DBMET01943 | DBMET01944 | |
| 0.049 | 0.02 | 0.052 | Histamine H1 receptor agonist | 0.052 0.015 DBMET01944 | DBMET01944 | |
| 0.061 | 0.033 | 0.098 | Protein kinase C eta inhibitor | 0.098 0.018 DBMET01944 0.065 0.031 DBMET01943 0.081 0.023 DBMET01945 0.081 0.023 DBMET01946 | DBMET01944 | |
| 0.059 | 0.032 | 0.059 | NMDA 2B receptor antagonist | 0.056 0.034 DBMET01944 | ||
| 0.07 | 0.042 | 0.083 | Bcl2 antagonist | 0.061 0.054 DBMET01947 0.083 0.029 DBMET01948 | DBMET01948 | |
| 0.076 | 0.049 | 0.169 | MAP-kinase-activated kinase 2 inhibitor | 0.169 0.007 DBMET01944 | DBMET01944 | |
| 0.064 | 0.038 | 0.068 | Phosphodiesterase 1C inhibitor | 0.068 0.032 DBMET01944 | DBMET01944 | |
| 0.102 | 0.075 | 0.177 | GABA C receptor antagonist | 0.177 0.019 DBMET01944 0.099 0.08 DBMET01943 | DBMET01944 | |
| 0.036 | 0.011 | 0.036 | Dopamine autoreceptor agonist | |||
| 0.05 | 0.026 | 0.059 | Benzodiazepine antagonist | 0.059 0.014 DBMET01944 | DBMET01944 | |
| 0.092 | 0.068 | 0.128 | MAP kinase kinase 1 inhibitor | 0.128 0.028 DBMET01944 | DBMET01944 | |
| 0.093 | 0.07 | 0.149 | Chemokine receptor antagonist | 0.133 0.04 DBMET01947 0.149 0.033 DBMET01948 | DBMET01948 | |
| 0.053 | 0.03 | 0.053 | Potassium channel (Inward rectifier) blocker | 0.05 0.034 DBMET01947 0.051 0.033 DBMET01948 | ||
| 0.116 | 0.094 | 0.134 | Interleukin 1 antagonist | 0.134 0.071 DBMET01944 | DBMET01944 | |
| 0.034 | 0.012 | 0.035 | MAP3K8 inhibitor | 0.035 0.01 DBMET01944 0.032 0.014 DBMET01947 0.028 0.023 DBMET01948 | DBMET01944 | |
| 0.087 | 0.066 | 0.152 | Protein kinase C delta inhibitor | 0.152 0.02 DBMET01944 | DBMET01944 | |
| 0.052 | 0.032 | 0.094 | Transforming growth factor beta 1 antagonist | 0.094 0.011 DBMET01944 | DBMET01944 | |
| 0.067 | 0.047 | 0.106 | Neuronal nicotinic receptor antagonist | 0.106 0.022 DBMET01944 | DBMET01944 | |
| 0.04 | 0.021 | 0.04 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.104 | 0.085 | 0.104 | Beta amyloid protein antagonist | |||
| 0.143 | 0.124 | 0.273 | DNA methylase inhibitor | 0.148 0.119 DBMET01944 0.273 0.037 DBMET01943 | DBMET01943 | |
| 0.029 | 0.01 | 0.029 | Urotensin II antagonist | 0.026 0.012 DBMET01944 0.02 0.019 DBMET01948 | ||
| 0.114 | 0.096 | 0.182 | Cytokine production inhibitor | 0.182 0.043 DBMET01944 | DBMET01944 | |
| 0.059 | 0.042 | 0.059 | Heat shock protein 90 beta antagonist | 0.055 0.048 DBMET01944 | ||
| 0.075 | 0.059 | 0.104 | Macrophage migration inhibitory factor inhibitor | 0.104 0.033 DBMET01943 | DBMET01943 | |
| 0.059 | 0.043 | 0.059 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.178 | 0.163 | 0.178 | Neuropeptide Y2 antagonist | 0.177 0.165 DBMET01944 | ||
| 0.032 | 0.017 | 0.036 | DNA topoisomerase IV inhibitor | 0.036 0.011 DBMET01944 | DBMET01944 | |
| 0.149 | 0.134 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.152 0.13 DBMET01944 | DBMET01944 | |
| 0.103 | 0.088 | 0.103 | Acetylcholine muscarinic antagonist | |||
| 0.075 | 0.061 | 0.104 | Acetylcholine nicotinic antagonist | 0.104 0.037 DBMET01944 | DBMET01944 | |
| 0.034 | 0.021 | 0.036 | Protein kinase C beta I inhibitor | 0.036 0.017 DBMET01944 0.032 0.027 DBMET01945 0.032 0.027 DBMET01946 | DBMET01944 | |
| 0.102 | 0.089 | 0.102 | Acetylcholine antagonist | |||
| 0.103 | 0.091 | 0.103 | Cholinergic antagonist | |||
| 0.062 | 0.05 | 0.062 | Fibroblast growth factor 2 antagonist | |||
| 0.035 | 0.023 | 0.035 | Adenosine uptake inhibitor | |||
| 0.106 | 0.095 | 0.106 | Acetylcholinesterase inhibitor | |||
| 0.076 | 0.065 | 0.076 | Neuropeptide Y antagonist | |||
| 0.047 | 0.037 | 0.047 | Cytokine production stimulant | |||
| 0.025 | 0.015 | 0.025 | CC chemokine 1 receptor antagonist | |||
| 0.111 | 0.102 | 0.12 | Growth factor antagonist | 0.12 0.092 DBMET01944 | DBMET01944 | |
| 0.052 | 0.043 | 0.165 | Pim-2 kinase inhibitor | 0.165 0.006 DBMET01944 | DBMET01944 | |
| 0.091 | 0.082 | 0.147 | Hedgehog signaling inhibitor | 0.147 0.025 DBMET01944 | DBMET01944 | |
| 0.065 | 0.057 | 0.072 | CXC chemokine receptor antagonist | 0.072 0.047 DBMET01944 | DBMET01944 | |
| 0.051 | 0.043 | 0.051 | CC chemokine 2 receptor antagonist | |||
| 0.047 | 0.039 | 0.047 | CC chemokine receptor 2B antagonist | 0.047 0.037 DBMET01944 | ||
| 0.14 | 0.133 | 0.14 | P-glycoprotein inhibitor | |||
| 0.194 | 0.188 | 0.317 | Vasodilator, coronary | 0.264 0.12 DBMET01947 0.317 0.074 DBMET01948 | DBMET01948 | |
| 0.124 | 0.119 | 0.192 | Polo-like kinase-3 inhibitor | 0.192 0.05 DBMET01944 | DBMET01944 | |
| 0.111 | 0.105 | 0.147 | Vascular endothelial growth factor 3 antagonist | 0.147 0.068 DBMET01944 | DBMET01944 | |
| 0.025 | 0.02 | 0.025 | Sigma 1 receptor antagonist | |||
| 0.078 | 0.073 | 0.088 | mTOR complex 2 inhibitor | 0.088 0.051 DBMET01944 | DBMET01944 | |
| 0.038 | 0.033 | 0.054 | Acid-sensing ion channel blocker | 0.054 0.013 DBMET01944 | DBMET01944 | |
| 0.085 | 0.081 | 0.121 | MAP kinase 8 inhibitor | 0.121 0.043 DBMET01944 0.112 0.049 DBMET01947 0.109 0.051 DBMET01948 | DBMET01944 | |
| 0.037 | 0.034 | 0.041 | CDK5/p25 inhibitor | 0.041 0.029 DBMET01944 | DBMET01944 | |
| 0.055 | 0.051 | 0.099 | Cyclin B1 inhibitor | 0.099 0.011 DBMET01944 | DBMET01944 | |
| 0.086 | 0.083 | 0.126 | Topoisomerase I inhibitor | 0.126 0.052 DBMET01947 0.108 0.063 DBMET01948 | DBMET01947 | |
| 0.027 | 0.024 | 0.045 | 5 Hydroxytryptamine 6 agonist | 0.045 0.005 DBMET01944 | DBMET01944 | |
| 0.04 | 0.037 | 0.04 | Oleamide hydrolase inhibitor | |||
| 0.03 | 0.028 | 0.03 | Vanilloid 4 antagonist | |||
| 0.046 | 0.045 | 0.046 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.016 | 0.015 | 0.034 | Histamine H4 receptor agonist | 0.034 0.006 DBMET01944 | DBMET01944 | |
| 0.047 | 0.046 | 0.172 | GABA A receptor antagonist | 0.172 0.007 DBMET01944 0.05 0.041 DBMET01947 | DBMET01944 | |
| 0.031 | 0.031 | 0.032 | Transforming growth factor beta 2 antagonist | 0.032 0.025 DBMET01944 | DBMET01944 | |
| 0.053 | 0.054 | 0.057 | Phosphodiesterase 1B inhibitor | 0.057 0.047 DBMET01944 | DBMET01944 | |
| 0.008 | 0.009 | 0.009 | Corticotropin releasing factor antagonist | 0.009 0.007 DBMET01944 | DBMET01944 | |
| 0.05 | 0.051 | 0.083 | CXC chemokine 4 receptor antagonist | 0.083 0.03 DBMET01944 | DBMET01944 | |
| 0.087 | 0.089 | 0.13 | Granulocyte macrophage colony stimulating factor antagonist | 0.13 0.046 DBMET01944 0.098 0.074 DBMET01947 | DBMET01944 | |
| 0.029 | 0.031 | 0.034 | Estrogen-related receptor beta antagonist | 0.034 0.02 DBMET01944 | DBMET01944 | |
| 0.015 | 0.017 | 0.02 | CC chemokine 9 receptor antagonist | 0.02 0.007 DBMET01944 0.02 0.007 DBMET01947 0.019 0.008 DBMET01948 | DBMET01947 | |
| 0.125 | 0.128 | 0.237 | LIM domain kinase 1 inhibitor | 0.237 0.045 DBMET01944 | DBMET01944 | |
| 0.029 | 0.032 | 0.086 | Kainate receptor 2 antagonist | 0.04 0.022 DBMET01944 0.086 0.005 DBMET01943 0.039 0.023 DBMET01948 | DBMET01943 | |
| 0.061 | 0.065 | 0.087 | Transforming growth factor antagonist | 0.087 0.029 DBMET01944 | DBMET01944 | |
| 0.046 | 0.051 | 0.174 | GABA receptor antagonist | 0.174 0.007 DBMET01944 | DBMET01944 | |
| 0.036 | 0.041 | 0.067 | NMDA receptor subunit 3B antagonist | 0.067 0.017 DBMET01944 0.054 0.022 DBMET01943 | DBMET01944 | |
| 0.041 | 0.048 | 0.053 | Benzodiazepine inverse agonist | 0.053 0.022 DBMET01944 0.046 0.035 DBMET01947 | DBMET01944 | |
| 0.039 | 0.046 | 0.08 | AMPA receptor antagonist | 0.08 0.017 DBMET01944 0.067 0.022 DBMET01943 0.08 0.017 DBMET01947 0.047 0.034 DBMET01948 | DBMET01947 | |
| 0.11 | 0.118 | 0.227 | Src kinase inhibitor | 0.124 0.104 DBMET01944 0.227 0.043 DBMET01945 | DBMET01945 | |
| 0.013 | 0.021 | 0.068 | Nicotinic alpha4 receptor agonist | 0.068 0.003 DBMET01944 | DBMET01944 | |
| 0.2 | 0.208 | 0.292 | Antiobesity | 0.292 0.122 DBMET01944 0.208 0.199 DBMET01943 | DBMET01944 | |
| 0.091 | 0.101 | 0.134 | Cholesterol synthesis inhibitor | 0.134 0.054 DBMET01943 | DBMET01943 | |
| 0.046 | 0.056 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.052 0.04 DBMET01944 | DBMET01944 | |
| 0.046 | 0.057 | 0.078 | CDK9/cyclin T1 inhibitor | 0.078 0.027 DBMET01944 | DBMET01944 | |
| 0.029 | 0.04 | 0.061 | Cyclin D3 inhibitor | 0.061 0.016 DBMET01944 | DBMET01944 | |
| 0.109 | 0.121 | 0.193 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.193 0.046 DBMET01944 | DBMET01944 | |
| 0.085 | 0.097 | 0.122 | Cystathionine beta-synthase inhibitor | 0.099 0.078 DBMET01944 0.122 0.056 DBMET01943 | DBMET01943 | |
| 0.068 | 0.081 | 0.078 | ErbB-3 antagonist | 0.078 0.063 DBMET01943 | DBMET01943 | |
| 0.044 | 0.058 | 0.082 | Cyclin B2 inhibitor | 0.082 0.014 DBMET01944 | DBMET01944 | |
| 0.134 | 0.149 | 0.241 | Aryl hydrocarbon receptor agonist | 0.241 0.082 DBMET01944 | DBMET01944 | |
| 0.08 | 0.094 | 0.174 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.174 0.044 DBMET01944 | DBMET01944 | |
| 0.044 | 0.059 | 0.085 | Cyclin B inhibitor | 0.085 0.013 DBMET01944 | DBMET01944 | |
| 0.028 | 0.044 | 0.032 | Benzodiazepine receptor peripheral-type antagonist | 0.032 0.03 DBMET01944 | DBMET01944 | |
| 0.056 | 0.072 | 0.085 | Protein kinase B alpha inhibitor | 0.085 0.038 DBMET01944 0.068 0.05 DBMET01946 | DBMET01944 | |
| 0.056 | 0.072 | 0.067 | Potassium channel (ATP-sensitive) blocker | 0.064 0.052 DBMET01944 0.067 0.047 DBMET01947 | DBMET01947 | |
| 0.05 | 0.067 | 0.117 | Cyclin-dependent kinase 4 inhibitor | 0.117 0.019 DBMET01944 | DBMET01944 | |
| 0.074 | 0.091 | 0.08 | Phosphodiesterase I inhibitor | 0.08 0.077 DBMET01944 | DBMET01944 | |
| 0.036 | 0.054 | 0.049 | CDK7/cyclin H inhibitor | 0.049 0.026 DBMET01944 | DBMET01944 | |
| 0.073 | 0.092 | 0.199 | Pim-1 kinase inhibitor | 0.199 0.015 DBMET01944 | DBMET01944 | |
| 0.06 | 0.079 | 0.131 | CC chemokine receptor antagonist | 0.102 0.034 DBMET01947 0.131 0.022 DBMET01948 | DBMET01948 | |
| 0.021 | 0.04 | 0.047 | Potassium channel small-conductance Ca-activated activator | 0.047 0.012 DBMET01944 | DBMET01944 | |
| 0.089 | 0.109 | 0.16 | MAP kinase kinase inhibitor | 0.16 0.046 DBMET01944 | DBMET01944 | |
| 0.011 | 0.031 | 0.027 | Cyclin T1 inhibitor | 0.027 0.006 DBMET01944 | DBMET01944 | |
| 0.101 | 0.121 | 0.203 | Protein kinase C nu inhibitor | 0.203 0.046 DBMET01944 0.123 0.09 DBMET01945 0.123 0.09 DBMET01946 | DBMET01944 | |
| 0.02 | 0.041 | 0.027 | LFA antagonist | 0.027 0.021 DBMET01943 | DBMET01943 | |
| 0.076 | 0.097 | 0.12 | Phosphodiesterase 7B inhibitor | 0.12 0.037 DBMET01944 | DBMET01944 | |
| 0.063 | 0.085 | 0.115 | Protein kinase A inhibitor | 0.115 0.036 DBMET01944 | DBMET01944 | |
| 0.043 | 0.065 | 0.072 | Nicotinic receptor alpha7 subunit antagonist | 0.072 0.02 DBMET01944 | DBMET01944 | |
| 0.1 | 0.122 | 0.164 | CDC-like kinase 1 inhibitor | 0.164 0.059 DBMET01944 | DBMET01944 | |
| 0.02 | 0.043 | 0.049 | Nicotinic alpha3beta4 receptor agonist | 0.049 0.005 DBMET01944 | DBMET01944 | |
| 0.028 | 0.051 | 0.192 | 5 Hydroxytryptamine 2C agonist | 0.192 0.004 DBMET01944 | DBMET01944 | |
| 0.08 | 0.102 | 0.099 | EphA2 antagonist | 0.099 0.077 DBMET01944 | DBMET01944 | |
| 0.04 | 0.063 | 0.068 | Nicotinic receptor alpha4 subunit antagonist | 0.068 0.018 DBMET01944 | DBMET01944 | |
| 0.07 | 0.095 | 0.084 | Platelet activating factor alpha antagonist | 0.084 0.075 DBMET01944 | DBMET01944 | |
| 0.024 | 0.049 | 0.037 | NMDA receptor subunit 3A antagonist | 0.037 0.027 DBMET01944 0.036 0.029 DBMET01943 | DBMET01944 | |
| 0.11 | 0.136 | 0.127 | MAP3K9 inhibitor | 0.127 0.101 DBMET01944 | DBMET01944 | |
| 0.081 | 0.108 | 0.136 | Aurora-B kinase inhibitor | 0.136 0.053 DBMET01944 | DBMET01944 | |
| 0.082 | 0.109 | 0.323 | c-Src kinase inhibitor | 0.323 0.015 DBMET01945 | DBMET01945 | |
| 0.039 | 0.066 | 0.073 | Glutamate (mGluR1) antagonist | 0.073 0.028 DBMET01944 0.055 0.043 DBMET01947 | DBMET01944 | |
| 0.038 | 0.066 | 0.081 | Topoisomerase II beta inhibitor | 0.081 0.013 DBMET01944 | DBMET01944 | |
| 0.1 | 0.128 | 0.114 | DNA repair enzyme inhibitor | 0.114 0.084 DBMET01944 | DBMET01944 | |
| 0.026 | 0.055 | 0.054 | Vascular adhesion protein 1 inhibitor | 0.054 0.012 DBMET01944 | DBMET01944 | |
| 0.04 | 0.069 | 0.059 | EphB4 antagonist | 0.059 0.039 DBMET01944 | DBMET01944 | |
| 0.042 | 0.072 | 0.07 | Thromboxane synthase inhibitor | 0.07 0.017 DBMET01943 | DBMET01943 | |
| 0.033 | 0.065 | 0.063 | Farnesyltransferase inhibitor | 0.061 0.019 DBMET01947 0.063 0.018 DBMET01948 | DBMET01948 | |
| 0.043 | 0.075 | 0.072 | Botulinum neurotoxin type A inhibitor | 0.072 0.023 DBMET01944 | DBMET01944 | |
| 0.063 | 0.097 | 0.099 | Viral attachment inhibitor | 0.091 0.031 DBMET01947 0.099 0.025 DBMET01948 | DBMET01948 | |
| 0.023 | 0.057 | 0.032 | CDK6/cyclin D3 inhibitor | 0.032 0.028 DBMET01944 | DBMET01944 | |
| 0.014 | 0.047 | 0.026 | Cyclin E2 inhibitor | 0.026 0.023 DBMET01944 | DBMET01944 | |
| 0.009 | 0.043 | 0.013 | Cyclin D2 inhibitor | 0.013 0.011 DBMET01944 | DBMET01944 | |
| 0.042 | 0.077 | 0.107 | Alpha 2 adrenoreceptor agonist | 0.107 0.013 DBMET01944 | DBMET01944 | |
| 0.055 | 0.089 | 0.083 | Protein kinase B gamma inhibitor | 0.083 0.043 DBMET01944 | DBMET01944 | |
| 0.096 | 0.131 | 0.144 | Tyrosine kinase inhibitor | 0.144 0.092 DBMET01944 | DBMET01944 | |
| 0.012 | 0.047 | 0.017 | CXC chemokine 5 receptor antagonist | 0.017 0.015 DBMET01948 | DBMET01948 | |
| 0.029 | 0.064 | 0.043 | Glutamate (mGluR5) antagonist | 0.043 0.037 DBMET01944 | DBMET01944 | |
| 0.032 | 0.068 | 0.06 | GABA B receptor antagonist | 0.06 0.012 DBMET01944 | DBMET01944 | |
| 0.086 | 0.122 | 0.19 | Glycogen synthase kinase-3 alpha inhibitor | 0.19 0.044 DBMET01944 | DBMET01944 | |
| 0.072 | 0.108 | 0.175 | Cyclin-dependent kinase 9 inhibitor | 0.175 0.028 DBMET01944 | DBMET01944 | |
| 0.019 | 0.056 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.023 DBMET01944 | DBMET01944 | |
| 0.027 | 0.064 | 0.042 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.042 0.04 DBMET01944 | DBMET01944 | |
| 0.093 | 0.131 | 0.111 | Transcription factor STAT6 inhibitor | 0.111 0.079 DBMET01944 | DBMET01944 | |
| 0.053 | 0.091 | 0.157 | Protein kinase B beta inhibitor | 0.075 0.049 DBMET01944 0.157 0.007 DBMET01946 | DBMET01946 | |
| 0.083 | 0.121 | 0.197 | Cyclin-dependent kinase 7 inhibitor | 0.197 0.035 DBMET01944 | DBMET01944 | |
| 0.038 | 0.076 | 0.057 | Lysine-specific demethylase 1A inhibitor | 0.057 0.032 DBMET01944 | DBMET01944 | |
| 0.027 | 0.065 | 0.038 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.025 DBMET01944 0.038 0.02 DBMET01943 | DBMET01943 | |
| 0.035 | 0.075 | 0.064 | Tyrosine-protein kinase EMT inhibitor | 0.064 0.034 DBMET01946 | DBMET01946 | |
| 0.041 | 0.082 | 0.076 | Cyclin A1 inhibitor | 0.076 0.017 DBMET01944 | DBMET01944 | |
| 0.046 | 0.087 | 0.111 | CDC7 inhibitor | 0.111 0.019 DBMET01944 | DBMET01944 | |
| 0.105 | 0.146 | 0.14 | Hexokinase inhibitor | 0.14 0.091 DBMET01944 | DBMET01944 | |
| 0.114 | 0.155 | 0.245 | DNA methyltransferase I inhibitor | 0.245 0.049 DBMET01943 | DBMET01943 | |
| 0.057 | 0.098 | 0.12 | ALK inhibitor | 0.12 0.03 DBMET01944 | DBMET01944 | |
| 0.05 | 0.092 | 0.069 | Glutamate (mGluR group I) antagonist | 0.069 0.05 DBMET01944 | DBMET01944 | |
| 0.068 | 0.109 | 0.085 | NADH dehydrogenase inhibitor | 0.085 0.065 DBMET01944 | DBMET01944 | |
| 0.018 | 0.06 | 0.024 | Complement factor 1r inhibitor | 0.024 0.023 DBMET01944 | DBMET01944 | |
| 0.033 | 0.079 | 0.069 | Alpha 1L adrenoreceptor agonist | 0.069 0.005 DBMET01944 | DBMET01944 | |
| 0.152 | 0.198 | 0.218 | DNA synthesis inhibitor | 0.218 0.097 DBMET01944 0.204 0.118 DBMET01943 0.17 0.169 DBMET01945 0.17 0.169 DBMET01946 0.2 0.124 DBMET01948 | DBMET01944 | |
| 0.04 | 0.087 | 0.05 | Glucosylceramidase inhibitor | 0.05 0.048 DBMET01944 | DBMET01944 | |
| 0.134 | 0.181 | 0.201 | Growth factor agonist | 0.163 0.115 DBMET01944 0.201 0.061 DBMET01947 0.153 0.134 DBMET01948 | DBMET01947 | |
| 0.058 | 0.106 | 0.109 | Glycine receptor antagonist | 0.109 0.025 DBMET01944 | DBMET01944 | |
| 0.013 | 0.062 | 0.043 | Nicotinic alpha4beta2 receptor agonist | 0.043 0.006 DBMET01944 | DBMET01944 | |
| 0.011 | 0.06 | 0.022 | Kainate receptor 4 antagonist | 0.022 0.02 DBMET01948 | DBMET01948 | |
| 0.024 | 0.074 | 0.04 | Protein kinase (CK2) beta inhibitor | 0.04 0.013 DBMET01944 | DBMET01944 | |
| 0.071 | 0.123 | 0.099 | Electrolyte absorption antagonist | 0.099 0.06 DBMET01944 0.09 0.075 DBMET01943 | DBMET01944 | |
| 0.102 | 0.155 | 0.141 | Aurora-C kinase inhibitor | 0.141 0.063 DBMET01944 | DBMET01944 | |
| 0.069 | 0.123 | 0.095 | Protein kinase (CK2) alpha inhibitor | 0.095 0.081 DBMET01944 | DBMET01944 | |
| 0.102 | 0.157 | 0.189 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.189 0.071 DBMET01944 | DBMET01944 | |
| 0.043 | 0.099 | 0.108 | Check point kinase 1 inhibitor | 0.108 0.025 DBMET01944 | DBMET01944 | |
| 0.025 | 0.081 | 0.036 | AMPA 4 receptor antagonist | 0.036 0.034 DBMET01943 | DBMET01943 | |
| 0.01 | 0.066 | 0.035 | Imidazoline I1 receptor antagonist | 0.035 0.005 DBMET01944 | DBMET01944 | |
| 0.042 | 0.099 | 0.093 | CDK1/cyclin B1 inhibitor | 0.093 0.031 DBMET01944 | DBMET01944 | |
| 0.073 | 0.131 | 0.118 | Beta glucuronidase inhibitor | 0.118 0.048 DBMET01944 | DBMET01944 | |
| 0.047 | 0.105 | 0.106 | Leucine-rich repeat kinase 2 inhibitor | 0.106 0.039 DBMET01944 | DBMET01944 | |
| 0.037 | 0.095 | 0.062 | Cyclin H inhibitor | 0.062 0.037 DBMET01944 | DBMET01944 | |
| 0.11 | 0.169 | 0.246 | MAP kinase kinase 2 inhibitor | 0.246 0.056 DBMET01944 | DBMET01944 | |
| 0.054 | 0.114 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.06 DBMET01944 | DBMET01944 | |
| 0.028 | 0.088 | 0.076 | CDK4/cyclin D1 inhibitor | 0.076 0.027 DBMET01944 | DBMET01944 | |
| 0.025 | 0.087 | 0.042 | Protein kinase (CK1) epsilon inhibitor | 0.042 0.021 DBMET01944 | DBMET01944 | |
| 0.044 | 0.105 | 0.056 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.056 0.053 DBMET01944 | DBMET01944 | |
| 0.06 | 0.122 | 0.111 | MAP kinase 9 inhibitor | 0.111 0.055 DBMET01944 | DBMET01944 | |
| 0.021 | 0.084 | 0.055 | NMDA 2A receptor antagonist | 0.055 0.034 DBMET01943 | DBMET01943 | |
| 0.007 | 0.07 | 0.019 | Cholecystokinin A agonist | 0.019 0.009 DBMET01945 | DBMET01945 | |
| 0.056 | 0.119 | 0.101 | Aurora-A kinase inhibitor | 0.101 0.065 DBMET01944 | DBMET01944 | |
| 0.005 | 0.068 | 0.026 | Kainate receptor 1 antagonist | 0.026 0.012 DBMET01943 | DBMET01943 | |
| 0.072 | 0.136 | 0.094 | Alpha 2d adrenoreceptor antagonist | 0.094 0.06 DBMET01944 | DBMET01944 | |
| 0.03 | 0.094 | 0.084 | Purinergic P2X4 antagonist | 0.084 0.006 DBMET01944 | DBMET01944 | |
| 0.007 | 0.071 | 0.032 | Prostaglandin H2 antagonist | 0.032 0.011 DBMET01943 | DBMET01943 | |
| 0.022 | 0.087 | 0.037 | ATR kinase inhibitor | 0.037 0.016 DBMET01944 | DBMET01944 | |
| 0.119 | 0.184 | 0.189 | Succinate dehydrogenase inhibitor | 0.189 0.058 DBMET01943 | DBMET01943 | |
| 0.098 | 0.163 | 0.135 | Protein kinase (CK1) gamma 3 inhibitor | 0.135 0.107 DBMET01944 | DBMET01944 | |
| 0.046 | 0.112 | 0.069 | Glutamate (mGluR) antagonist | 0.069 0.062 DBMET01944 | DBMET01944 | |
| 0.026 | 0.093 | 0.04 | Phenylethanolamine N methyltransferase inhibitor | 0.04 0.028 DBMET01944 | DBMET01944 | |
| 0.031 | 0.098 | 0.055 | CDK1/cyclin B inhibitor | 0.055 0.051 DBMET01944 | DBMET01944 | |
| 0.087 | 0.154 | 0.121 | Protein kinase (CK1) gamma 1 inhibitor | 0.121 0.096 DBMET01944 | DBMET01944 | |
| 0.018 | 0.086 | 0.061 | Urate transporter 1 inhibitor | 0.061 0.014 DBMET01943 | DBMET01943 | |
| 0.036 | 0.104 | 0.063 | Alpha 1b adrenoreceptor agonist | 0.063 0.016 DBMET01944 | DBMET01944 | |
| 0.077 | 0.146 | 0.095 | CDC-like kinase 3 inhibitor | 0.095 0.091 DBMET01944 | DBMET01944 | |
| 0.085 | 0.154 | 0.19 | CDC-like kinase 2 inhibitor | 0.19 0.072 DBMET01944 | DBMET01944 | |
| 0.015 | 0.085 | 0.058 | Kainate receptor antagonist | 0.058 0.017 DBMET01943 | DBMET01943 | |
| 0.019 | 0.089 | 0.057 | Alpha 1d adrenoreceptor agonist | 0.057 0.012 DBMET01944 | DBMET01944 | |
| 0.067 | 0.137 | 0.084 | CC chemokine 5 receptor agonist | 0.084 0.051 DBMET01948 | DBMET01948 | |
| 0.033 | 0.104 | 0.051 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.051 0.047 DBMET01944 | DBMET01944 | |
| 0.029 | 0.1 | 0.061 | CDK4/cyclin D inhibitor | 0.061 0.036 DBMET01944 | DBMET01944 | |
| 0.031 | 0.103 | 0.06 | Aconitate hydratase inhibitor | 0.06 0.026 DBMET01943 | DBMET01943 | |
| 0.036 | 0.11 | 0.227 | MAP kinase 14 inhibitor | 0.224 0.009 DBMET01947 0.227 0.009 DBMET01948 | DBMET01948 | |
| 0.147 | 0.221 | 0.21 | Nitric-oxide synthase stimulant | 0.21 0.073 DBMET01944 0.179 0.131 DBMET01948 | DBMET01944 | |
| 0.08 | 0.154 | 0.148 | NADPH oxidase inhibitor | 0.148 0.056 DBMET01944 | DBMET01944 | |
| 0.034 | 0.109 | 0.073 | Protein kinase C iota inhibitor | 0.073 0.03 DBMET01944 | DBMET01944 | |
| 0.052 | 0.128 | 0.102 | Protein kinase (CK2) inhibitor | 0.102 0.062 DBMET01944 | DBMET01944 | |
| 0.031 | 0.108 | 0.066 | Carbamoyl phosphate synthetase inhibitor | 0.066 0.038 DBMET01943 | DBMET01943 | |
| 0.067 | 0.145 | 0.078 | T cell inhibitor | 0.078 0.076 DBMET01944 | DBMET01944 | |
| 0.107 | 0.186 | 0.18 | I kappa B kinase epsilon inhibitor | 0.18 0.089 DBMET01944 | DBMET01944 | |
| 0.027 | 0.108 | 0.065 | NMDA 2C receptor antagonist | 0.065 0.038 DBMET01943 | DBMET01943 | |
| 0.031 | 0.114 | 0.078 | Cyclin A2 inhibitor | 0.078 0.033 DBMET01944 | DBMET01944 | |
| 0.14 | 0.226 | 0.175 | RNA-directed DNA polymerase inhibitor | 0.175 0.143 DBMET01944 | DBMET01944 | |
| 0.045 | 0.132 | 0.102 | CDK/cyclin complex inhibitor | 0.102 0.05 DBMET01944 | DBMET01944 | |
| 0.042 | 0.13 | 0.068 | MAP kinase 10 inhibitor | 0.068 0.067 DBMET01944 | DBMET01944 | |
| 0.109 | 0.198 | 0.143 | MAP kinase kinase 4 inhibitor | 0.143 0.077 DBMET01944 | DBMET01944 | |
| 0.009 | 0.098 | 0.02 | Alpha 2b adrenoreceptor agonist | 0.02 0.01 DBMET01944 | DBMET01944 | |
| 0.038 | 0.128 | 0.109 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.109 0.031 DBMET01944 | DBMET01944 | |
| 0.019 | 0.109 | 0.065 | Factor XIa inhibitor | 0.06 0.013 DBMET01947 0.065 0.01 DBMET01948 | DBMET01948 | |
| 0.065 | 0.155 | 0.093 | AMP-activated protein kinase stimulant | 0.093 0.081 DBMET01943 | DBMET01943 | |
| 0.107 | 0.198 | 0.199 | Dyrk kinase inhibitor | 0.199 0.099 DBMET01944 | DBMET01944 | |
| 0.028 | 0.119 | 0.074 | Cyclin A inhibitor | 0.074 0.035 DBMET01944 | DBMET01944 | |
| 0.035 | 0.128 | 0.091 | Porphobilinogen synthase inhibitor | 0.091 0.04 DBMET01943 | DBMET01943 | |
| 0.063 | 0.156 | 0.171 | Cyclin-dependent kinase inhibitor | 0.171 0.047 DBMET01944 | DBMET01944 | |
| 0.082 | 0.177 | 0.101 | Interleukin 2 antagonist | 0.101 0.09 DBMET01944 | DBMET01944 | |
| 0.079 | 0.174 | 0.12 | Peroxidase inhibitor | 0.12 0.1 DBMET01944 | DBMET01944 | |
| 0.037 | 0.132 | 0.071 | I kappa B kinase 2 inhibitor | 0.071 0.03 DBMET01944 | DBMET01944 | |
| 0.106 | 0.204 | 0.187 | Death-associated protein kinase 3 inhibitor | 0.187 0.082 DBMET01944 | DBMET01944 | |
| 0.04 | 0.139 | 0.067 | CYP2A6 inhibitor | 0.067 0.063 DBMET01944 | DBMET01944 | |
| 0.045 | 0.145 | 0.098 | Stem cell growth factor agonist | 0.098 0.047 DBMET01947 | DBMET01947 | |
| 0.05 | 0.15 | 0.124 | Alcohol dehydrogenase inhibitor | 0.124 0.032 DBMET01943 | DBMET01943 | |
| 0.083 | 0.184 | 0.193 | CDC-like kinase 4 inhibitor | 0.193 0.071 DBMET01944 | DBMET01944 | |
| 0.042 | 0.146 | 0.136 | Cyclin-dependent kinase 1 inhibitor | 0.136 0.047 DBMET01944 | DBMET01944 | |
| 0.056 | 0.161 | 0.083 | MAP kinase kinase 7 inhibitor | 0.083 0.038 DBMET01944 | DBMET01944 | |
| 0.065 | 0.171 | 0.131 | Tyrosine-protein kinase receptor antagonist | 0.131 0.077 DBMET01944 | DBMET01944 | |
| 0.021 | 0.128 | 0.055 | CC chemokine 5 receptor antagonist | 0.055 0.031 DBMET01948 | DBMET01948 | |
| 0.084 | 0.193 | 0.196 | Clk dual-specificity kinase inhibitor | 0.196 0.082 DBMET01944 | DBMET01944 | |
| 0.048 | 0.158 | 0.09 | CDK2/cyclin A inhibitor | 0.09 0.068 DBMET01944 | DBMET01944 | |
| 0.095 | 0.208 | 0.176 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.176 0.109 DBMET01944 | DBMET01944 | |
| 0.099 | 0.212 | 0.133 | Death-associated protein kinase 1 inhibitor | 0.133 0.073 DBMET01944 | DBMET01944 | |
| 0.027 | 0.141 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.036 DBMET01944 | DBMET01944 | |
| 0.013 | 0.128 | 0.037 | Factor XI inhibitor | 0.033 0.024 DBMET01947 0.037 0.019 DBMET01948 | DBMET01948 | |
| 0.08 | 0.195 | 0.139 | Diuretic | 0.139 0.086 DBMET01943 | DBMET01943 | |
| 0.053 | 0.168 | 0.117 | GABA C receptor agonist | 0.105 0.062 DBMET01944 0.117 0.052 DBMET01943 | DBMET01943 | |
| 0.042 | 0.157 | 0.099 | I kappa B kinase inhibitor | 0.099 0.04 DBMET01944 | DBMET01944 | |
| 0.083 | 0.199 | 0.209 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.209 0.07 DBMET01944 | DBMET01944 | |
| 0.028 | 0.145 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 DBMET01944 | DBMET01944 | |
| 0.052 | 0.169 | 0.107 | Cyclin-dependent kinase 2 inhibitor | 0.107 0.063 DBMET01944 | DBMET01944 | |
| 0.147 | 0.265 | 0.198 | Tyrosine 3 hydroxylase inhibitor | 0.198 0.139 DBMET01943 | DBMET01943 | |
| 0.005 | 0.124 | 0.018 | Alpha 2a adrenoreceptor agonist | 0.018 0.011 DBMET01944 | DBMET01944 | |
| 0.022 | 0.141 | 0.134 | p38 MAP kinase inhibitor | 0.129 0.024 DBMET01947 0.134 0.023 DBMET01948 | DBMET01948 | |
| 0.052 | 0.173 | 0.111 | Ferrochelatase inhibitor | 0.111 0.06 DBMET01943 | DBMET01943 | |
| 0.023 | 0.143 | 0.054 | Protein kinase C theta inhibitor | 0.054 0.047 DBMET01944 | DBMET01944 | |
| 0.036 | 0.157 | 0.065 | Aryl hydrocarbon receptor antagonist | 0.065 0.045 DBMET01944 | DBMET01944 | |
| 0.052 | 0.176 | 0.101 | Chelator | 0.101 0.076 DBMET01943 | DBMET01943 | |
| 0.143 | 0.269 | 0.204 | Insulysin inhibitor | 0.204 0.151 DBMET01943 | DBMET01943 | |
| 0.038 | 0.17 | 0.092 | I kappa B kinase 1 inhibitor | 0.092 0.027 DBMET01944 | DBMET01944 | |
| 0.129 | 0.262 | 0.241 | Cholesterol antagonist | 0.241 0.132 DBMET01943 | DBMET01943 | |
| 0.024 | 0.161 | 0.042 | Glutamate (mGluR4) antagonist | 0.042 0.034 DBMET01943 | DBMET01943 | |
| 0.029 | 0.169 | 0.116 | Sphingosine 1-phosphate receptor 5 agonist | 0.116 0.006 DBMET01943 | DBMET01943 | |
| 0.005 | 0.151 | 0.019 | Alpha 2c adrenoreceptor agonist | 0.019 0.013 DBMET01944 | DBMET01944 | |
| 0.029 | 0.178 | 0.074 | Rho-associated kinase I inhibitor | 0.074 0.052 DBMET01944 | DBMET01944 | |
| 0.107 | 0.259 | 0.199 | Catenin beta inhibitor | 0.199 0.032 DBMET01943 | DBMET01943 | |
| 0.049 | 0.21 | 0.101 | TRKA antagonist | 0.101 0.088 DBMET01944 | DBMET01944 | |
| 0.083 | 0.244 | 0.124 | Adenylate cyclase stimulant | 0.124 0.116 DBMET01943 | DBMET01943 | |
| 0.024 | 0.187 | 0.061 | Phosphodiesterase 4B inhibitor | 0.061 0.056 DBMET01947 | DBMET01947 | |
| 0.014 | 0.177 | 0.048 | Thromboxane A2 antagonist | 0.048 0.038 DBMET01943 | DBMET01943 | |
| 0.063 | 0.229 | 0.156 | Cell adhesion inhibitor | 0.156 0.043 DBMET01943 | DBMET01943 | |
| 0.098 | 0.264 | 0.139 | Phospholipase C inhibitor | 0.139 0.129 DBMET01944 | DBMET01944 | |
| 0.016 | 0.185 | 0.052 | Thromboxane antagonist | 0.052 0.04 DBMET01943 | DBMET01943 | |
| 0.035 | 0.205 | 0.101 | Protein kinase (CK1) delta inhibitor | 0.101 0.091 DBMET01944 | DBMET01944 | |
| 0.008 | 0.183 | 0.02 | Alpha 1a adrenoreceptor agonist | 0.02 0.019 DBMET01944 | DBMET01944 | |
| 0.042 | 0.22 | 0.109 | Uric acid excretion stimulant | 0.109 0.045 DBMET01943 | DBMET01943 | |
| 0.083 | 0.266 | 0.159 | Non-steroidal antiinflammatory agent | 0.159 0.105 DBMET01943 | DBMET01943 | |
| 0.042 | 0.227 | 0.111 | Cell adhesion molecule inhibitor | 0.111 0.028 DBMET01943 | DBMET01943 | |
| 0.036 | 0.226 | 0.116 | Potassium channel activator | 0.1 0.047 DBMET01947 0.116 0.035 DBMET01948 | DBMET01948 | |
| 0.06 | 0.25 | 0.097 | CDK3/cyclin E inhibitor | 0.097 0.095 DBMET01944 | DBMET01944 | |
| 0.117 | 0.31 | 0.249 | Antithrombotic | 0.249 0.127 DBMET01943 | DBMET01943 | |
| 0.032 | 0.227 | 0.09 | Cyclin-dependent kinase 5 inhibitor | 0.09 0.085 DBMET01944 | DBMET01944 | |
| 0.075 | 0.272 | 0.142 | Insulin secretagoues | 0.142 0.083 DBMET01943 | DBMET01943 | |
| 0.01 | 0.213 | 0.057 | Prostaglandin EP2 antagonist | 0.057 0.043 DBMET01943 | DBMET01943 | |
| 0.023 | 0.229 | 0.093 | Phosphodiesterase IV inhibitor | 0.093 0.05 DBMET01947 0.077 0.065 DBMET01948 | DBMET01947 | |
| 0.012 | 0.22 | 0.08 | Prostaglandin antagonist | 0.08 0.023 DBMET01943 | DBMET01943 | |
| 0.045 | 0.257 | 0.119 | Phosphodiesterase inhibitor | 0.119 0.083 DBMET01947 | DBMET01947 | |
| 0.121 | 0.335 | 0.566 | Toll-Like receptor 7 agonist | 0.231 0.166 DBMET01943 0.526 0.027 DBMET01947 0.566 0.021 DBMET01948 | DBMET01948 | |
| 0.013 | 0.232 | 0.048 | Neurokinin antagonist | 0.048 0.037 DBMET01946 | DBMET01946 | |
| 0.118 | 0.339 | 0.558 | Toll-Like receptor agonist | 0.23 0.167 DBMET01943 0.52 0.028 DBMET01947 0.558 0.022 DBMET01948 | DBMET01948 | |
| 0.032 | 0.258 | 0.11 | Protein kinase (CK1) inhibitor | 0.11 0.1 DBMET01944 | DBMET01944 | |
| 0.008 | 0.24 | 0.044 | Substance P antagonist | 0.044 0.022 DBMET01946 | DBMET01946 | |
| 0.008 | 0.244 | 0.019 | Potassium channel (Inward rectifier) 11 blocker | 0.017 0.015 DBMET01947 0.019 0.011 DBMET01948 | DBMET01948 | |
| 0.004 | 0.248 | 0.02 | Prostaglandin D2 antagonist | 0.02 0.019 DBMET01943 | DBMET01943 | |
| 0.117 | 0.367 | 0.244 | Apoptosis antagonist | 0.244 0.133 DBMET01943 | DBMET01943 | |
| 0.007 | 0.29 | 0.039 | Neurokinin 1 antagonist | 0.039 0.03 DBMET01946 | DBMET01946 | |
| 0.096 | 0.406 | 0.245 | Antibacterial | 0.245 0.182 DBMET01948 | DBMET01948 | |
| 0.008 | 0.337 | 0.071 | Phosphodiesterase 4A inhibitor | 0.071 0.024 DBMET01947 0.068 0.025 DBMET01948 | DBMET01947 | |
| 0.05 | 0.406 | 0.37 | Vasodilator | 0.22 0.09 DBMET01945 0.336 0.037 DBMET01947 0.37 0.028 DBMET01948 | DBMET01948 | |
| 0.022 | 0.388 | 0.271 | Bronchodilator | 0.244 0.013 DBMET01947 0.271 0.011 DBMET01948 | DBMET01948 | |
| 0.036 | 0.437 | 0.324 | Platelet antagonist | 0.324 0.045 DBMET01943 | DBMET01943 | |
| 0.015 | 0.437 | 0.179 | HIV-1 integrase inhibitor | 0.076 0.041 DBMET01945 0.179 0.005 DBMET01946 | DBMET01946 | |
| 0.004 | 0.605 | 0.034 | 1,3-Beta-glucan synthase inhibitor | 0.034 0.007 DBMET01945 0.034 0.007 DBMET01946 | DBMET01946 | |
| 0.066 | 0.695 | 0.212 | Interleukin 2 agonist | 0.212 0.169 DBMET01943 | DBMET01943 | |
| 0.039 | 0.681 | 0.233 | Cyclophilin D inhibitor | 0.233 0.232 DBMET01943 | DBMET01943 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |